Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery Vs Stereotactic Body Radiotherapy

Overview

Journal JAMA Netw Open

Publisher American Medical Association

Specialty General Medicine

Date 2019 Nov 21

PMID 31747032

Citations 23

Authors

Alexander Chi

Wei Fang

Yeping Sun

Sijin Wen

Affiliations

Soon will be listed here.

Abstract

Importance: Previous comparisons of surgery and stereotactic body radiotherapy (SBRT) for early-stage (ES) non-small cell lung cancer (NSCLC) did not account for the extent of regional lymph node examination (LNE) during surgery.

Objective: To compare long-term overall survival (OS) of patients with ES NSCLC after surgery vs SBRT when the extent of regional LNE in patients undergoing surgery is thoroughly considered.

Design, Setting, And Participants: Cohort study with survival comparisons using the multivariable Cox proportional hazards model and after propensity score matching. Data from the National Cancer Database were analyzed from October 28, 2018, through April 18, 2019. Patients with ES NSCLC diagnosed between January 1, 2004, and December 31, 2015, who underwent any curative-intent surgery or SBRT were included.

Main Outcomes And Measures: Long-term OS.

Results: Of 104 709 total patients, 91 330 underwent surgery (42 508 [46.5%] male; median [interquartile range] age, 68 [61-75] years) and 13 379 received SBRT (6065 [45.3%] male; median [interquartile range] age, 75 [68-81] years). Surgery, especially lobectomy (hazard ratio [HR], 0.53; 95% CI, 0.50-0.56), and regional LNE, especially when more than 10 lymph nodes were examined (HR, 0.73; 95% CI, 0.69-0.77), were associated with better long-term OS (P < .001). Pneumonectomy was not associated with reduced mortality risk when 0 nodes were examined (HR for stage T1, 1.43; 95% CI, 0.67-3.06; P = .35; HR for stage T2-T3, 0.62; 95% CI, 0.34-1.13; P = .12) or when more than 15 nodes were examined for stage T1 disease in patients younger than 80 years (HR, 0.77; 95% CI, 0.54-1.09; P = .14) or when patients aged 80 years or older received regional LNE of any extent (>15 nodes examined: HR for stage T1, 0.65; 95% CI, 0.16-2.64; P = .54; HR for stage T2-T3, 0.90; 95% CI, 0.50-1.60; P = .71). Less extensive surgery was not associated with improved OS when 0 nodes were examined in patients aged 80 years or older with stage T2 to T3 tumors (HR for lobectomy, 0.90; 95% CI, 0.65-1.25; P = .53) and in selected operable patients older than 75 years with stage T1 tumors (HR for lobectomy, 1.07; 95% CI, 0.57-2.00; P = .84).

Conclusions And Relevance: This study found that, overall, surgery coupled with regional LNE of appropriate extent was associated with the best long-term OS in patients with ES NSCLC.

Citing Articles

Effect of patient and tumor characteristics on respiratory motion in early-stage peripheral lung cancer (Tis ~ T2bN0M0) treated with stereotactic body radiation therapy (SBRT).

Mitsuhashi N, Tominaga D, Ikeda H, Shiina F, Fukaya K, Nemoto Y Rep Pract Oncol Radiother. 2025; 29(4):468-477.

PMID: 39895962 PMC: 11785381. DOI: 10.5603/rpor.101531.

Association between health-related quality of life and perioperative exercise capacity in older postoperative patients with non-small cell lung cancer.

Oikawa M, Hanada M, Nagura H, Takeuchi R, Miyazaki T, Doi R J Thorac Dis. 2025; 16(12):8300-8308.

PMID: 39831246 PMC: 11740081. DOI: 10.21037/jtd-24-1265.

Comparative evaluation of negative lymph node count, positive lymph node count, and lymph node ratio in prognostication of survival following completely resection for non-small cell lung cancer: a multicenter population-based analysis.

Huang Q, Chen S, Xiao Y, Chen W, He S, Xie B Front Surg. 2024; 11:1506850.

PMID: 39717353 PMC: 11663925. DOI: 10.3389/fsurg.2024.1506850.

Wedge Resection versus Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors ≤8 mm.

Mansur A, Saleem Z, Beqari J, Mathey-Andrews C, Potter A, Cranor J Curr Oncol. 2024; 31(3):1529-1542.

PMID: 38534949 PMC: 10969215. DOI: 10.3390/curroncol31030116.

LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival data analysis.

Kovacs A, Trasi K, Barabas M, Gal K, Csiki E, Sipos D Pathol Oncol Res. 2024; 30:1611589.

PMID: 38414671 PMC: 10896905. DOI: 10.3389/pore.2024.1611589.

References

Rochon P, Gurwitz J, Sykora K, Mamdani M, Streiner D, Garfinkel S . Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ. 2005; 330(7496):895-7. PMC: 556167. DOI: 10.1136/bmj.330.7496.895. View

Mokhles S, Verstegen N, Maat A, Birim O, Bogers A, Mokhles M . Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer. 2015; 87(3):283-9. DOI: 10.1016/j.lungcan.2015.01.005. View

Chang J, Senan S, Paul M, Mehran R, Louie A, Balter P . Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015; 16(6):630-7. PMC: 4489408. DOI: 10.1016/S1470-2045(15)70168-3. View

Hamaji M, Chen F, Matsuo Y, Kawaguchi A, Morita S, Ueki N . Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015; 99(4):1122-9. DOI: 10.1016/j.athoracsur.2014.11.009. View

Smeltzer M, Faris N, Ray M, Osarogiagbon R . Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent. JAMA Oncol. 2017; 4(1):80-87. PMC: 5833630. DOI: 10.1001/jamaoncol.2017.2993. View

Darling G, Allen M, Decker P, Ballman K, Malthaner R, Inculet R . Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030.... J Thorac Cardiovasc Surg. 2011; 141(3):662-70. PMC: 5082844. DOI: 10.1016/j.jtcvs.2010.11.008. View

Yerokun B, Yang C, Gulack B, Li X, Mulvihill M, Gu L . A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017; 154(2):675-686.e4. DOI: 10.1016/j.jtcvs.2017.02.065. View

Fitzmaurice C, Akinyemiju T, Al Lami F, Alam T, Alizadeh-Navaei R, Allen C . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2018; 4(11):1553-1568. PMC: 6248091. DOI: 10.1001/jamaoncol.2018.2706. View

Cho S, Song I, Yang H, Kim K, Jheon S . Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer. Ann Thorac Surg. 2013; 96(1):239-45. DOI: 10.1016/j.athoracsur.2013.03.050. View

10.

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

11.

Normand S, Sykora K, Li P, Mamdani M, Rochon P, Anderson G . Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ. 2005; 330(7498):1021-3. PMC: 557157. DOI: 10.1136/bmj.330.7498.1021. View

12.

Stokes W, Bronsert M, Meguid R, Blum M, Jones B, Koshy M . Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018; 36(7):642-651. DOI: 10.1200/JCO.2017.75.6536. View

13.

Gajra A, Newman N, Gamble G, Kohman L, Graziano S . Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003; 21(6):1029-34. DOI: 10.1200/JCO.2003.07.010. View

14.

Ramirez R, Wang C, Miller L, Adair C, Berry A, Yu X . Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer. J Clin Oncol. 2012; 30(23):2823-8. DOI: 10.1200/JCO.2011.39.2589. View

15.

Grills I, Mangona V, Welsh R, Chmielewski G, McInerney E, Martin S . Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010; 28(6):928-35. DOI: 10.1200/JCO.2009.25.0928. View

16.

Rosen J, Salazar M, Wang Z, Yu J, Decker R, Kim A . Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016; 152(1):44-54.e9. DOI: 10.1016/j.jtcvs.2016.03.060. View

17.

Watanabe S, Asamura H . Lymph node dissection for lung cancer: significance, strategy, and technique. J Thorac Oncol. 2009; 4(5):652-7. DOI: 10.1097/JTO.0b013e31819cce50. View

18.

Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J . Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010; 303(11):1070-6. PMC: 2907644. DOI: 10.1001/jama.2010.261. View

19.

Crabtree T, Puri V, Robinson C, Bradley J, Broderick S, Patterson G . Analysis of first recurrence and survival in patients with stage I non-small cell lung cancer treated with surgical resection or stereotactic radiation therapy. J Thorac Cardiovasc Surg. 2014; 147(4):1183-1191. PMC: 4113038. DOI: 10.1016/j.jtcvs.2013.11.057. View

20.

Osarogiagbon R, Ogbata O, Yu X . Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2013; 97(2):385-93. PMC: 3946669. DOI: 10.1016/j.athoracsur.2013.09.058. View